Official recall notice

FDA DrugClass IINotable

Exenatide Injection Recall (Sep 2026) – Amneal Pharmaceuticals

Product: Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213, India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1685-1

Recall date
2026-09-30
Category
Drug
FDA class
Class II

Why it was recalled

Hazard

Defective Delivery System: Possibility of no medication in the prefilled pen.

One email a week when there are new recalls. Confirm by email; unsubscribe anytime.

Product description

Defective Delivery System: Possibility of no medication in the prefilled pen.

Affected products

Lot #: AP250095A, Exp 2/28/2027

Verify with the official notice →
Share:

Related Recalls

2026-10-09 · FDA_DRUG
FDA Recall: Par Pharmaceutical: Brevital Sodium 500 mg/vial for Injection
Par Pharmaceutical
2026-10-01 · FDA_DRUG
FDA Recall: Greenwich: Glutathione Injection
Greenwich
2026-10-01 · FDA_DRUG
FDA Recall: Greenwich: Glutathione Injection
Greenwich
2026-09-30 · FDA_DRUG
FDA Recall: Walgreens Lubricant Eye Drops, Carboxymethylcellulose sodium 0.5%, Lubricant Eye Drops, Sterile, 0.5
Sterling Pharmaceutical Services LLC